Several studies have linked PHT to high‐grade CRS, inflammation markers (i.e. ferritin and CRP), and tocilizumab or steroid treatment,5, 27, 44 which all indicate that patients with a greater degree of inflammation are more likely to experience PHT. Here, CRP is linked to pulmonary hypertension, primary, 1.